Not available
Quote | Xenon Pharmaceuticals Inc. (NASDAQ:XENE)
Last: | $40.01 |
---|---|
Change Percent: | -0.1% |
Open: | $39.92 |
Close: | $40.01 |
High: | $40.31 |
Low: | $39.18 |
Volume: | 237,187 |
Last Trade Date Time: | 04/22/2024 03:00:00 am |
News | Xenon Pharmaceuticals Inc. (NASDAQ:XENE)
VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, announced two oral presentations highlighting XEN1101 clinical data at the American Academy of Neurology (AAN) 2024 Annual Meeting in Denver,...
VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the 2024 Bloom Burton & Co. Healthcare Investor Conference taking place April 16-17, 2024. ...
Message Board Posts | Xenon Pharmaceuticals Inc. (NASDAQ:XENE)
Subject | By | Source | When |
---|---|---|---|
MEAN $XENE @ it aGAIN | TheFinalCD | investorshub | 10/06/2021 4:20:22 PM |
I bought some yesterday at close (26) hopefully | LowFloatLopes | investorshub | 10/05/2021 11:07:45 AM |
$34 CLOSE= WOW | TheFinalCD | investorshub | 10/05/2021 12:51:00 AM |
Don't really care about the semantics just the | rynlrt | investorshub | 10/04/2021 11:12:14 PM |
$XENE Has $3.5M in debt | BottomBounce | investorshub | 10/04/2021 10:45:01 PM |
News, Short Squeeze, Breakout and More Instantly...
Xenon Pharmaceuticals Inc. Company Name:
XENE Stock Symbol:
NASDAQ Market:
Xenon Pharmaceuticals Inc. Website:
VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neuroscience-focused biopharmaceutic...
VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, announced two oral presentations highlighting XEN1101 clinical data at the American Academy of Neurology (AAN) 2024 Annual Meeting in Denver,...
VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neurology-focused biopharmaceutical ...